Who owns the OMBLASTYS (OMBURTAMAB) trademark?

The OMBLASTYS (OMBURTAMAB) trademark is owned by Y-mAbs Therapeutics, Inc.

What is the serial number for OMBLASTYS (OMBURTAMAB)?

The USPTO serial number for OMBLASTYS (OMBURTAMAB) is 88886712.

What is the registration number for OMBLASTYS (OMBURTAMAB)?

OMBLASTYS (OMBURTAMAB) is registered under USPTO registration number 6338259.

OMB

USPTO Trademark Record

REGISTERED

OMBLASTYS (OMBURTAMAB)

Q: What class is the OMBLASTYS (OMBURTAMAB) trademark registered in?

The OMBLASTYS (OMBURTAMAB) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 88886712·Reg 6338259·Filed Apr 24, 2020

Owner Y-mAbs Therapeutics, Inc

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

OMBLASTYS (OMBURTAMAB) (Serial No. 88886712), Registration No. 6338259, is a registered US trademark filed on Apr 24, 2020 by Y-mAbs Therapeutics, Inc. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Renewal window: May 04, 2027207 days remaining

Mark Intelligence

OMBLASTYS (OMBURTAMAB) (Reg. #6338259) is a registered US trademark that has been protecting its owner, Y-mAbs Therapeutics, Inc, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 24, 2020

SERIAL

88886712

REG#

6338259

REGISTERED

May 04, 2021

Owner

Applicant

Y-mAbs Therapeutics, Inc

Entity

Corporation

State

Address

230 Park Avenue, Suite 3350, New York, NY, 10169

Country

Attorney

NameAndrew N. Spivak

Law firm

Andrew N. Spivak MOSAIC LEGAL GROUP, PLLC

Docket

14218-039

Address

5185 MACARTHUR BOULEVARD, NW, SUITE 350, WASHINGTON, DC 20016-3341, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 24, 2020

Serial Number88886712

Registration No.6338259

Registration DateMay 04, 2021

Status DateMay 04, 2021

Published for OppositionFeb 16, 2021

Mark TypeDesign with words

Attorney Docket14218-039

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

23 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 04, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

May 04, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Feb 16, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 16, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 27, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ELECTRONIC RECORD REVIEW COMPLETE

Aug 27, 2020

ELECTRONIC RECORD REVIEW COMPLETE

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Aug 21, 2020

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 20, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 20, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 20, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Aug 17, 2020

ASSIGNED TO LIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jul 29, 2020

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

SUSPENSION LETTER WRITTEN

Jul 24, 2020

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Jul 24, 2020

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jul 24, 2020

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jul 20, 2020

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jul 20, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 20, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jul 20, 2020

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Jul 17, 2020

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 07, 2020

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 06, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 28, 2020

NEW APPLICATION ENTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

OMB

OMBLASTYS (131 I-OMBURTAMAB-YCWD)

79358602

Y-mAbs Therapeutics, Inc

REGISTERED

OMB

OMBLASTYS

88320059

Y-mAbs Therapeutics, Inc

ABANDONED

OMBLASTYS (OMBURTAMAB)

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Y-mAbs Therapeutics, Inc

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrew N. Spivak

Resources

Company